Peer-reviewedCC BY 4.0Frontiers in Endocrinology8 Oct 2026

Editorial: Long-acting growth hormone therapy in pediatric growth hormone deficiency

Anastasia Ibba¹
Giuseppa Patti^2,3
Sandro Loche⁴

4 affiliations

¹Pediatric Endocrinology Unit and Newborn Screening Centre, Pediatric Hospital Microcitemico “A. Cao”, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Brotzu
²Department of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini
³Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health - University of Genova
⁴Research Area for Innovative Therapies in Endocrinopathies, Bambino Gesù Children Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)

Open at source PDF DOI Cite

Case Report: Case series: growth hormone replacement for severe growth hormone deficiency during BRAF inhibitor therapy in pediatric low-grade glioma: long-term follow-up
Marta Panciroli, Antonio Verrico, Marco Crocco +8
Frontiers in Endocrinology8 Oct 2026Peer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters
Xiaoxue Tian, Dan Zhang, Yihui Wang +6
iRADIOLOGY30 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
Caregiver Experiences, Treatment Decision-Making, and Unmet Information Needs During Pediatric Growth Hormone Therapy: A Nationwide Cross-Sectional Survey in Korea.
Yeryeon Jung, Dohee Ahn, Jeong-Yeon Kim +1
Patient preference and adherence28 Oct 2026Peer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMCPMC
Novel variant and enteroendocrine hormone deficiency in a patient with proline and glutamate‐rich protein with a coiled coil domain 1 (PERCC1) associated enteropathy: New diagnostic and therapeutic insights
Teresa Di Chio, Daniela Gattini, Christina Belza +7
JPGN reports16 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Growth Hormone Deficiency and Systemic Metabolic Remodeling: Insights from Metabolomics and Lipidomics
Sarmed Al-Samerria, Sally Radovick
Metabolites2 Oct 2026Peer-reviewedCC BY 4.0Endocrinology & metabolismCrossref

Cite

BibTeX RIS

BibTeX

@article{ibba2026editorial,
  title = {{Editorial: Long-acting growth hormone therapy in pediatric growth hormone deficiency}},
  author = {Anastasia Ibba and Giuseppa Patti and Sandro Loche},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.2005952},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.2005952/full},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Editorial: Long-acting growth hormone therapy in pediatric growth hormone deficiency
AU  - Anastasia Ibba
AU  - Giuseppa Patti
AU  - Sandro Loche
PY  - 2026
DA  - 2026/10/08
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.2005952
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.2005952/full
SN  - 1664-2392
ER  -

Related

Cite